Zhengzi Qian-Zhou
Department Of Lymphoma / State Key Laboratory Of Druggability Evaluation And Systematic Translational Medicine, Key Laboratory Of Cancer Prevention And Therapy
Tianjin, 300060, China
Tianjin, 300060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Correction to: Risk factors for POD24 in patients with previously untreated follicular lymphoma: a systematic review and meta‑analysis.
Journal: Annals of hematology
Published: October 18, 2022
Genetic characteristics involving the PD-1/PD-L1/L2 and CD73/A2aR axes and the immunosuppressive microenvironment in DLBCL.
Journal: Journal for immunotherapy of cancer
Published: March 14, 2022
Electrocardiographic characteristics of diffuse large B-cell lymphoma patients treated with anthracycline-based chemotherapy.
Journal: Journal of electrocardiology
Published: February 29, 2020
TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.
Journal: Materials science & engineering. C, Materials for biological applications
Published: July 05, 2017
Upconverting and persistent luminescent nanocarriers for accurately imaging-guided photothermal therapy.
Journal: Materials science & engineering. C, Materials for biological applications
Published: March 25, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026